Product Information:

TAPOGET IR 75mg Tablets contain Tapentadol Immediate Release (IR) 75mg, a centrally acting dual-mechanism analgesic that combines:

1. Mu-opioid receptor agonism
2. Norepinephrine reuptake inhibition (NRI)

This dual action provides effective relief for moderate to severe acute pain, with a potentially improved gastrointestinal tolerability profile compared to traditional opioids like oxycodone or tramadol.

⚠️ Important Safety Note:

Tapentadol is a Schedule H1 controlled substance in Pakistan due to its opioid properties. It carries risks of respiratory depression, dependence, abuse, and misuse. Use only as prescribed for short-term management of acute pain.

Uses of (TAPOGET IR 75MG TABLETS):

1. Short-term treatment of moderate to severe acute pain (e.g., postoperative pain, musculoskeletal injury, dental pain)
2. Management of acute flare-ups of chronic pain (off-label, with caution)
3. Alternative to tramadol or traditional opioids when better GI tolerance is desired

Key Benefits of (TAPOGET IR 75MG TABLETS):

1. Dual mechanism enhances analgesic efficacy
2. Lower incidence of nausea, vomiting, and constipation than classic opioids
3. No active metabolites (unlike tramadol)—safer in hepatic impairment
4. Rapid onset of action (within 30–60 minutes)

How To Use (TAPOGET IR 75MG TABLETS):

1. Take every 4–6 hours as needed for pain, with or without food.
2. Swallow whole with water—do not crush, chew, or split.
3. Maximum daily dose: Typically not exceeding 600mg/day (i.e., 8 tablets of 75mg), but individualized based on pain severity and tolerance.
4. Use the lowest effective dose for the shortest duration (usually ≤5–7 days for acute pain).

When Not to Use (TAPOGET IR 75MG TABLETS):

Do not use if you have:

1. Significant respiratory depression or acute asthma
2. Paralytic ileus or severe GI obstruction
3. Hypersensitivity to tapentadol
4. Concurrent use of MAO inhibitors (or within 14 days)
5. Severe hepatic impairment (Child-Pugh C)

🆘 Contraindicated in children <18 years.

Side Effects of (TAPOGET IR 75MG TABLETS):

Common:

1. Nausea, dizziness, headache
2. Somnolence (drowsiness)
3. Dry mouth, constipation (less than morphine/tramadol)

Less common:

1. Vomiting, abdominal pain
2. Fatigue, sweating

Serious (require monitoring):

1. Respiratory depression (especially with overdose or concomitant CNS depressants)
2. Serotonin syndrome (if combined with SSRIs, SNRIs, MAOIs)
3. Seizures (rare; higher risk in epilepsy or with high doses)
4. Physical dependence and withdrawal with prolonged use
5. Discontinue and seek emergency help if slow/shallow breathing, confusion, or hallucinations occur.

Dosage: (TAPOGET IR 75MG TABLETS):

1. Adults: 50–100mg every 4–6 hours as needed
2. Starting dose: Often 50mg; 75mg may be used in opioid-tolerant patients or severe pain
3. Elderly or mild hepatic/renal impairment: Start at 50mg; extend dosing interval
4. Maximum single dose: 100mg
5. Maximum daily dose: 600mg

Who It’s For (TAPOGET IR 75MG TABLETS):

Adults requiring short-term management of moderate to severe acute pain who may benefit from an opioid with reduced GI side effects.

Warnings & Precautions:

1. Avoid alcohol or other CNS depressants (benzodiazepines, sedatives)—↑ risk of respiratory depression
2. Use caution in elderly, debilitated, or COPD patients
3. Risk of addiction—even at prescribed doses—limit to short-term use
4. Do not discontinue abruptly after prolonged use—taper to avoid withdrawal

Drug Interactions:

1. CNS depressants (alcohol, benzodiazepines, barbiturates): ↑ Sedation, respiratory depression
2. SSRIs, SNRIs, MAOIs: ↑ Risk of serotonin syndrome
3. CYP2D6 inhibitors (paroxetine, fluoxetine): May slightly ↑ tapentadol levels
4. Always inform your doctor about all medications.

Additional Information:

Store below 30°C in a dry place, protected from light and moisture. Keep in a secure location away from children and unauthorized persons. Do not use after the expiration date. Available by prescription only in Pakistan (Schedule H1).